3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
22
Neoplasms
13
Breast Neoplasms
9
Lung Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Lymphedema
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Quality of Life
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neurocognitive Disorders
1
Neoplasms, Plasma Cell
1
Muscular Atrophy
1
Multiple Myeloma
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Exercise
×
90 days
×
Clear all
No trials found.